HC Wainwright & Co. Reiterates Buy on Repare Therapeutics, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Repare Therapeutics (NASDAQ:RPTX) and maintained a price target of $10.
October 24, 2024 | 7:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Repare Therapeutics and maintained a $10 price target, indicating confidence in the company's future performance.
The reiteration of a Buy rating and maintenance of a $10 price target by HC Wainwright & Co. suggests positive sentiment and confidence in Repare Therapeutics' future performance. This could lead to increased investor interest and a potential short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100